Doxycycline Dosing for Cellulitis
For cellulitis treatment in adults, doxycycline is dosed at 100 mg orally twice daily, with a typical treatment duration of 5-10 days depending on clinical response.
Adult Dosing
The standard regimen is:
- 100 mg orally twice daily 1, 2
- Some sources recommend a loading dose of 200 mg on day 1 (given as 100 mg every 12 hours), followed by 100 mg daily maintenance dosing 2, though the twice-daily regimen is more commonly used for skin infections
Duration: 5-10 days, individualized based on clinical response 3, 4
Pediatric Dosing (≥8 years old)
For children weighing <100 pounds (45 kg):
- 4.4 mg/kg/day divided into two doses (maximum 200 mg/day) 5
- Alternative calculation: 2 mg/lb divided into two doses on day 1, then 1 mg/lb daily (as single or divided dose) on subsequent days 2
For children weighing ≥100 pounds:
- Use adult dosing: 100 mg twice daily 2
Critical caveat: Tetracyclines should NOT be used in children <8 years of age 3, 4, 5 unless benefits clearly outweigh risks (courses ≤21 days are considered safe for all ages per recent evidence 5).
Clinical Context for Doxycycline Use
Doxycycline is recommended as an alternative oral agent for cellulitis in specific scenarios 3, 4:
When to Use Doxycycline:
- MRSA coverage needed: For purulent cellulitis or when MRSA risk factors are present (previous MRSA infection, local prevalence >10-15%, injection drug use) 3, 4, 6
- Combination therapy: When covering both β-hemolytic streptococci and MRSA, combine doxycycline with a β-lactam (e.g., amoxicillin, cephalexin) 3, 4
- Alternative to first-line agents: When clindamycin or TMP-SMX are unavailable or contraindicated 1
When NOT to Use Doxycycline Alone:
- Nonpurulent cellulitis (no drainage/abscess): β-lactams (penicillin, cephalexin, amoxicillin) are preferred as first-line because typical cellulitis is caused by β-hemolytic streptococci, and doxycycline's activity against streptococci is uncertain 3, 6, 7
- If using doxycycline for MRSA coverage in nonpurulent cellulitis, must add a β-lactam for streptococcal coverage 3, 4, 6
Important Considerations
Absorption: Doxycycline can be taken with food or milk without significantly affecting absorption, which helps reduce GI side effects 2
Recent evidence: A 2024 propensity-matched study found doxycycline had similar clinical failure rates (6%) compared to cephalexin for presumed streptococcal skin infections, suggesting it may be a reasonable alternative in regions with low tetracycline resistance 8. However, this contradicts guideline recommendations that prioritize β-lactams for nonpurulent cellulitis.
Strength of recommendation: Doxycycline for MRSA coverage in skin infections is graded A-II by IDSA guidelines 3, 4, meaning it's based on at least one randomized controlled trial but not necessarily the strongest evidence level.